Market Research

Global Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031

Best Price Guarantee Length Publisher Published Date SKU
from $3,600 295 Pages Knowledge Based Value (KBV) Research August, 2024 KBV19060286
Best Price Guarantee
Price from $3,600
Length 295 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date August, 2024
SKU KBV19060286

Global Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031


The Global Peripheral Artery Disease Market size is expected to reach $7.1 billion by 2031, rising at a market growth of 6.9% CAGR during the forecast period.

Europe has a high prevalence of PAD risk factors, including an aging population, high rates of smoking, and increasing incidence of diabetes and hypertension. Europe's strong healthcare systems, particularly in countries like Germany, France, and the United Kingdom, contribute to the region's significant market share. Consequently, the European region would acquire nearly 30% of the total market share by 2031.

Parotid artery disease is a common cardiovascular disorder that frequently results in mobility challenges and discomfort. High blood pressure, or hypertension, is an additional significant risk factor for PAD. According to the World Health Organization (WHO), hypertension affects approximately 1.28 billion adults aged 30-79 years everywhere in the world. Hence, as the prevalence of PAD continues to rise, the demand for effective treatments and management strategies will drive market growth.

Additionally, the rapid advancements in medical technology are significantly transforming the landscape of PAD treatment, offering new hope and improved patient outcomes. Minimally invasive procedures are another area where technological advancements have profoundly impacted. Thus, such advancements are driving the growth of the market.

However, Drug-eluting stents, atherectomy devices, and minimally invasive procedures, while highly effective, come with substantial price tags that can be prohibitive for many patients. Furthermore, the high costs associated with advanced PAD treatments can stifle innovation and market growth. Hence, the high cost of advanced PAD treatments is a significant barrier to market growth.

Moreover, the economic downturn of the pandemic also posed significant challenges. Many individuals faced financial hardships due to job losses and reduced incomes, affecting their ability to afford medical care. High treatment costs, already a barrier for many PAD patients, became even more prohibitive during the pandemic. Healthcare providers also faced significant challenges during the pandemic. Thus, the pandemic had an overall negative impact on the market.

Product Type Outlook

Based on product type, the market is bifurcated into devices and drugs. The devices segment procured 41% revenue share in the market in 2023. In advanced cases where pharmaceutical treatments alone are insufficient, medical devices are essential for the diagnosis, intervention, and management of PAD. The devices segment includes various products such as diagnostic imaging tools, angioplasty balloons, stents, and atherectomy devices.

End User Outlook

On the basis of end user, the market is classified into specialty clinics and hospitals. The specialty clinics segment witnessed 45% revenue share in the market in 2023. Specialty clinics are known for their patient-centered approach, providing personalized care plans and closer patient monitoring. Improved health outcomes are the result of this emphasis on individualized treatment, which also increases patient satisfaction and patient adherence to treatment protocols.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 39% revenue share in the market in 2023. There are numerous factors that contribute to this dominance, including the high prevalence of PAD risk factors in the region, including diabetes, hypertension, obesity, and smoking.

List of Key Companies Profiled
  • Becton, Dickinson and Company
  • Bayer AG
  • Koninklijke Philips N.V.
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Biotronik SE & Co. KG
Global Peripheral Artery Disease Market Report Segmentation

By Product Type
  • Drugs
  • Antiplatelet Medicines
  • Statins
  • Anti Hypertensive Medication
  • Others
  • Devices
  • Peripheral Stents
  • Peripheral Angioplasty Balloons
  • Peripheral Catheters
  • Plaque Modification Devices
  • Inferior Vena Cava Filters
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories
By End User
  • Hospitals
  • Specialty Clinics
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Peripheral Artery Disease Market, by Product Type
1.4.2 Global Peripheral Artery Disease Market, by End User
1.4.3 Global Peripheral Artery Disease Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Peripheral Artery Disease Market by Product Type
4.1 Global Drugs Market by Region
4.2 Global Peripheral Artery Disease Market by Drugs Type
4.2.1 Global Antiplatelet Medicines Market by Region
4.2.2 Global Statins Market by Region
4.2.3 Global Anti Hypertensive Medication Market by Region
4.2.4 Global Others Market by Region
4.3 Global Devices Market by Region
4.4 Global Peripheral Artery Disease Market by Devices Type
4.4.1 Global Peripheral Stents Market by Region
4.4.2 Global Peripheral Angioplasty Balloons Market by Region
4.4.3 Global Peripheral Catheters Market by Region
4.4.4 Global Plaque Modification Devices Market by Region
4.4.5 Global Inferior Vena Cava Filters Market by Region
4.4.6 Global Hemodynamic Flow Alteration Devices Market by Region
4.4.7 Global Peripheral Accessories Market by Region
Chapter 5. Global Peripheral Artery Disease Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Specialty Clinics Market by Region
Chapter 6. Global Peripheral Artery Disease Market by Region
6.1 North America Peripheral Artery Disease Market
6.1.1 North America Peripheral Artery Disease Market by Product Type
6.1.1.1 North America Drugs Market by Region
6.1.1.2 North America Peripheral Artery Disease Market by Drugs Type
6.1.1.2.1 North America Antiplatelet Medicines Market by Country
6.1.1.2.2 North America Statins Market by Country
6.1.1.2.3 North America Anti Hypertensive Medication Market by Country
6.1.1.2.4 North America Others Market by Country
6.1.1.3 North America Devices Market by Region
6.1.1.4 North America Peripheral Artery Disease Market by Devices Type
6.1.1.4.1 North America Peripheral Stents Market by Country
6.1.1.4.2 North America Peripheral Angioplasty Balloons Market by Country
6.1.1.4.3 North America Peripheral Catheters Market by Country
6.1.1.4.4 North America Plaque Modification Devices Market by Country
6.1.1.4.5 North America Inferior Vena Cava Filters Market by Country
6.1.1.4.6 North America Hemodynamic Flow Alteration Devices Market by Country
6.1.1.4.7 North America Peripheral Accessories Market by Country
6.1.2 North America Peripheral Artery Disease Market by End User
6.1.2.1 North America Hospitals Market by Country
6.1.2.2 North America Specialty Clinics Market by Country
6.1.3 North America Peripheral Artery Disease Market by Country
6.1.3.1 US Peripheral Artery Disease Market
6.1.3.1.1 US Peripheral Artery Disease Market by Product Type
6.1.3.1.2 US Peripheral Artery Disease Market by End User
6.1.3.2 Canada Peripheral Artery Disease Market
6.1.3.2.1 Canada Peripheral Artery Disease Market by Product Type
6.1.3.2.2 Canada Peripheral Artery Disease Market by End User
6.1.3.3 Mexico Peripheral Artery Disease Market
6.1.3.3.1 Mexico Peripheral Artery Disease Market by Product Type
6.1.3.3.2 Mexico Peripheral Artery Disease Market by End User
6.1.3.4 Rest of North America Peripheral Artery Disease Market
6.1.3.4.1 Rest of North America Peripheral Artery Disease Market by Product Type
6.1.3.4.2 Rest of North America Peripheral Artery Disease Market by End User
6.2 Europe Peripheral Artery Disease Market
6.2.1 Europe Peripheral Artery Disease Market by Product Type
6.2.1.1 Europe Drugs Market by Country
6.2.1.2 Europe Peripheral Artery Disease Market by Drugs Type
6.2.1.2.1 Europe Antiplatelet Medicines Market by Country
6.2.1.2.2 Europe Statins Market by Country
6.2.1.2.3 Europe Anti Hypertensive Medication Market by Country
6.2.1.2.4 Europe Others Market by Country
6.2.1.3 Europe Devices Market by Country
6.2.1.4 Europe Peripheral Artery Disease Market by Devices Type
6.2.1.4.1 Europe Peripheral Stents Market by Country
6.2.1.4.2 Europe Peripheral Angioplasty Balloons Market by Country
6.2.1.4.3 Europe Peripheral Catheters Market by Country
6.2.1.4.4 Europe Plaque Modification Devices Market by Country
6.2.1.4.5 Europe Inferior Vena Cava Filters Market by Country
6.2.1.4.6 Europe Hemodynamic Flow Alteration Devices Market by Country
6.2.1.4.7 Europe Peripheral Accessories Market by Country
6.2.2 Europe Peripheral Artery Disease Market by End User
6.2.2.1 Europe Hospitals Market by Country
6.2.2.2 Europe Specialty Clinics Market by Country
6.2.3 Europe Peripheral Artery Disease Market by Country
6.2.3.1 Germany Peripheral Artery Disease Market
6.2.3.1.1 Germany Peripheral Artery Disease Market by Product Type
6.2.3.1.2 Germany Peripheral Artery Disease Market by End User
6.2.3.2 UK Peripheral Artery Disease Market
6.2.3.2.1 UK Peripheral Artery Disease Market by Product Type
6.2.3.2.2 UK Peripheral Artery Disease Market by End User
6.2.3.3 France Peripheral Artery Disease Market
6.2.3.3.1 France Peripheral Artery Disease Market by Product Type
6.2.3.3.2 France Peripheral Artery Disease Market by End User
6.2.3.4 Russia Peripheral Artery Disease Market
6.2.3.4.1 Russia Peripheral Artery Disease Market by Product Type
6.2.3.4.2 Russia Peripheral Artery Disease Market by End User
6.2.3.5 Spain Peripheral Artery Disease Market
6.2.3.5.1 Spain Peripheral Artery Disease Market by Product Type
6.2.3.5.2 Spain Peripheral Artery Disease Market by End User
6.2.3.6 Italy Peripheral Artery Disease Market
6.2.3.6.1 Italy Peripheral Artery Disease Market by Product Type
6.2.3.6.2 Italy Peripheral Artery Disease Market by End User
6.2.3.7 Rest of Europe Peripheral Artery Disease Market
6.2.3.7.1 Rest of Europe Peripheral Artery Disease Market by Product Type
6.2.3.7.2 Rest of Europe Peripheral Artery Disease Market by End User
6.3 Asia Pacific Peripheral Artery Disease Market
6.3.1 Asia Pacific Peripheral Artery Disease Market by Product Type
6.3.1.1 Asia Pacific Drugs Market by Country
6.3.1.2 Asia Pacific Peripheral Artery Disease Market by Drugs Type
6.3.1.2.1 Asia Pacific Antiplatelet Medicines Market by Country
6.3.1.2.2 Asia Pacific Statins Market by Country
6.3.1.2.3 Asia Pacific Anti Hypertensive Medication Market by Country
6.3.1.2.4 Asia Pacific Others Market by Country
6.3.1.3 Asia Pacific Devices Market by Country
6.3.1.4 Asia Pacific Peripheral Artery Disease Market by Devices Type
6.3.1.4.1 Asia Pacific Peripheral Stents Market by Country
6.3.1.4.2 Asia Pacific Peripheral Angioplasty Balloons Market by Country
6.3.1.4.3 Asia Pacific Peripheral Catheters Market by Country
6.3.1.4.4 Asia Pacific Plaque Modification Devices Market by Country
6.3.1.4.5 Asia Pacific Inferior Vena Cava Filters Market by Country
6.3.1.4.6 Asia Pacific Hemodynamic Flow Alteration Devices Market by Country
6.3.1.4.7 Asia Pacific Peripheral Accessories Market by Country
6.3.2 Asia Pacific Peripheral Artery Disease Market by End User
6.3.2.1 Asia Pacific Hospitals Market by Country
6.3.2.2 Asia Pacific Specialty Clinics Market by Country
6.3.3 Asia Pacific Peripheral Artery Disease Market by Country
6.3.3.1 China Peripheral Artery Disease Market
6.3.3.1.1 China Peripheral Artery Disease Market by Product Type
6.3.3.1.2 China Peripheral Artery Disease Market by End User
6.3.3.2 Japan Peripheral Artery Disease Market
6.3.3.2.1 Japan Peripheral Artery Disease Market by Product Type
6.3.3.2.2 Japan Peripheral Artery Disease Market by End User
6.3.3.3 India Peripheral Artery Disease Market
6.3.3.3.1 India Peripheral Artery Disease Market by Product Type
6.3.3.3.2 India Peripheral Artery Disease Market by End User
6.3.3.4 South Korea Peripheral Artery Disease Market
6.3.3.4.1 South Korea Peripheral Artery Disease Market by Product Type
6.3.3.4.2 South Korea Peripheral Artery Disease Market by End User
6.3.3.5 Singapore Peripheral Artery Disease Market
6.3.3.5.1 Singapore Peripheral Artery Disease Market by Product Type
6.3.3.5.2 Singapore Peripheral Artery Disease Market by End User
6.3.3.6 Malaysia Peripheral Artery Disease Market
6.3.3.6.1 Malaysia Peripheral Artery Disease Market by Product Type
6.3.3.6.2 Malaysia Peripheral Artery Disease Market by End User
6.3.3.7 Rest of Asia Pacific Peripheral Artery Disease Market
6.3.3.7.1 Rest of Asia Pacific Peripheral Artery Disease Market by Product Type
6.3.3.7.2 Rest of Asia Pacific Peripheral Artery Disease Market by End User
6.4 LAMEA Peripheral Artery Disease Market
6.4.1 LAMEA Peripheral Artery Disease Market by Product Type
6.4.1.1 LAMEA Drugs Market by Country
6.4.1.2 LAMEA Peripheral Artery Disease Market by Drugs Type
6.4.1.2.1 LAMEA Antiplatelet Medicines Market by Country
6.4.1.2.2 LAMEA Statins Market by Country
6.4.1.2.3 LAMEA Anti Hypertensive Medication Market by Country
6.4.1.2.4 LAMEA Others Market by Country
6.4.1.3 LAMEA Devices Market by Country
6.4.1.4 LAMEA Peripheral Artery Disease Market by Devices Type
6.4.1.4.1 LAMEA Peripheral Stents Market by Country
6.4.1.4.2 LAMEA Peripheral Angioplasty Balloons Market by Country
6.4.1.4.3 LAMEA Peripheral Catheters Market by Country
6.4.1.4.4 LAMEA Plaque Modification Devices Market by Country
6.4.1.4.5 LAMEA Inferior Vena Cava Filters Market by Country
6.4.1.4.6 LAMEA Hemodynamic Flow Alteration Devices Market by Country
6.4.1.4.7 LAMEA Peripheral Accessories Market by Country
6.4.2 LAMEA Peripheral Artery Disease Market by End User
6.4.2.1 LAMEA Hospitals Market by Country
6.4.2.2 LAMEA Specialty Clinics Market by Country
6.4.3 LAMEA Peripheral Artery Disease Market by Country
6.4.3.1 Brazil Peripheral Artery Disease Market
6.4.3.1.1 Brazil Peripheral Artery Disease Market by Product Type
6.4.3.1.2 Brazil Peripheral Artery Disease Market by End User
6.4.3.2 Argentina Peripheral Artery Disease Market
6.4.3.2.1 Argentina Peripheral Artery Disease Market by Product Type
6.4.3.2.2 Argentina Peripheral Artery Disease Market by End User
6.4.3.3 UAE Peripheral Artery Disease Market
6.4.3.3.1 UAE Peripheral Artery Disease Market by Product Type
6.4.3.3.2 UAE Peripheral Artery Disease Market by End User
6.4.3.4 Saudi Arabia Peripheral Artery Disease Market
6.4.3.4.1 Saudi Arabia Peripheral Artery Disease Market by Product Type
6.4.3.4.2 Saudi Arabia Peripheral Artery Disease Market by End User
6.4.3.5 South Africa Peripheral Artery Disease Market
6.4.3.5.1 South Africa Peripheral Artery Disease Market by Product Type
6.4.3.5.2 South Africa Peripheral Artery Disease Market by End User
6.4.3.6 Nigeria Peripheral Artery Disease Market
6.4.3.6.1 Nigeria Peripheral Artery Disease Market by Product Type
6.4.3.6.2 Nigeria Peripheral Artery Disease Market by End User
6.4.3.7 Rest of LAMEA Peripheral Artery Disease Market
6.4.3.7.1 Rest of LAMEA Peripheral Artery Disease Market by Product Type
6.4.3.7.2 Rest of LAMEA Peripheral Artery Disease Market by End User
Chapter 7. Company Profiles
7.1 Becton, Dickinson, and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.6 SWOT Analysis
7.8 Boston Scientific Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 SWOT Analysis
7.10. Biotronik SE & Co. KG
7.10.1 Company Overview
7.10.2 SWOT Analysis
Chapter 8. Winning Imperatives for Peripheral Artery Disease Market

$3,600
$4,320
$6,048

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings